HAL Stock Analysis: Halliburton | NYSE
Oil & Gas Equipment & Services | NYSE, USA | Market Cap: 28.579m USD | 12M Return: 56.7% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 450M
EPS Trend: -77.5%
Qual. Beats: 3
Rev. Trend: -65.1%
Qual. Beats: 0
Warnings
No concerns identified
Tailwinds
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Halliburton Company is a global oilfield services provider that supplies products and services to the energy industry across two main segments: Completion and Production, and Drilling and Evaluation. The Completion and Production segment delivers stimulation, sand control, cementing, well completion tools, artificial lift, coiled tubing, pipeline services, and specialty chemicals, while the Drilling and Evaluation segment provides drilling fluids, drilling systems, wireline and perforating services, drill bits, and digital and AI-based subsurface solutions, as well as testing, subsea, and integrated asset management services. The company is headquartered in Houston, Texas, and was founded in 1919.
As a member of the GICS Oil & Gas Equipment & Services sub-industry, Halliburton operates as a service provider rather than a producer, meaning its revenue is largely tied to the capital and operating spending cycles of upstream exploration and production companies. It is generally considered one of the three largest diversified oilfield service firms globally, alongside Schlumberger and Baker Hughes.
- North America frac activity rebounds lifting Completion and Production revenue
- International drilling contracts in Middle East and Latin America expand
- Oil price volatility shapes customer capex and service pricing power
| Net Income: 1.54b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA -2.62 > 1.0 |
| NWC/Revenue: 27.06% < 20% (prev 25.30%; Δ 1.76% < -1%) |
| CFO/TA 0.11 > 3% & CFO 2.82b > Net Income 1.54b |
| Net Debt (7.00b) to EBITDA (4.11b): 1.70 < 3 |
| Current Ratio: 2.08 > 1.5 & < 3 |
| Outstanding Shares: last quarter (839.0m) vs 12m ago -3.12% < -2% |
| Gross Margin: 15.31% > 18% (prev 18.17%; Δ -2.85% > 0.5%) |
| Asset Turnover: 88.11% > 50% (prev 89.59%; Δ -1.48% > 0%) |
| Interest Coverage Ratio: 8.57 > 6 (EBIT TTM 2.96b / Interest Expense TTM 345.0m) |
| A: 0.24 (Total Current Assets 11.5b - Total Current Liabilities 5.54b) / Total Assets 25.1b |
| B: 0.61 (Retained Earnings 15.4b / Total Assets 25.1b) |
| C: 0.12 (EBIT TTM 2.96b / Avg Total Assets 25.2b) |
| D: 0.76 (Book Value of Equity 10.8b / Total Liabilities 14.3b) |
| Altman-Z'' = 5.14 = AAA |
| DSRI: 1.02 (Receivables 5.20b/5.20b, Revenue 22.2b/22.6b) |
| GMI: 1.19 (GM 18.17% / 15.31%) |
| AQI: 1.12 (AQ_t 0.34 / AQ_t-1 0.30) |
| SGI: 0.98 (Revenue 22.2b / 22.6b) |
| TATA: -0.05 (NI 1.54b - CFO 2.82b) / TA 25.1b) |
| Beneish M = -2.79 (Cap -4..+1) = A |
As of July 05, 2026, the stock is trading at USD 32.96 with a total of 9,431,200 shares traded. Over the past week, the price has changed by -4.93%, over one month by -19.67%, over three months by -12.48% and over the past year by +56.71%.
Current recommended Stop Loss: 31.40 (which is 4.7% or 1.4 ATR below the current price).
Halliburton has received a consensus analysts rating of 4.15. Therefore, it is recommended to buy HAL.
- StrongBuy: 15
- Buy: 5
- Hold: 4
- Sell: 2
- StrongSell: 1
| Analysts Target Price | 44.2 | 34.2% |
P/E Trailing = 18.9006
P/E Forward = 13.2626
P/S = 1.2891
P/B = 2.6511
P/EG = 0.8959
Revenue TTM = 22.2b USD
EBIT TTM = 2.96b USD
EBITDA TTM = 4.11b USD
Long Term Debt = 7.07b USD (from longTermDebt, last quarter)
Short Term Debt = 333.0m USD (from shortTermDebt, last quarter)
Debt = 9.00b USD (from shortLongTermDebtTotal, last quarter) + Leases 921.0m
Net Debt = 7.00b USD (calculated: Debt 9.00b - CCE 2.00b)
Enterprise Value = 35.6b USD (28.6b + Debt 9.00b - CCE 2.00b)
Interest Coverage Ratio = 8.57 (Ebit TTM 2.96b / Interest Expense TTM 345.0m)
EV/FCF = 21.20x (Enterprise Value 35.6b / FCF TTM 1.68b)
FCF Yield = 4.72% (FCF TTM 1.68b / Enterprise Value 35.6b)
FCF Margin = 7.57% (FCF TTM 1.68b / Revenue TTM 22.2b)
Net Margin = 6.95% (Net Income TTM 1.54b / Revenue TTM 22.2b)
Gross Margin = 15.31% ((Revenue TTM 22.2b - Cost of Revenue TTM 18.8b) / Revenue TTM)
Gross Margin QoQ = 14.62% (prev 16.44%)
Tobins Q-Ratio = 1.42 (Enterprise Value 35.6b / Total Assets 25.1b)
Interest Expense / Debt = 3.83% (Interest Expense 345.0m / Debt 9.00b)
Taxrate = 23.65% (481.0m / 2.03b)
NOPAT = 2.26b (EBIT 2.96b * (1 - 23.65%))
Current Ratio = 2.08 (Total Current Assets 11.5b / Total Current Liabilities 5.54b)
Debt / Equity = 0.83 (Debt 9.00b / totalStockholderEquity, last quarter 10.8b)
Debt / EBITDA = 1.70 (Net Debt 7.00b / EBITDA 4.11b)
Debt / FCF = 4.17 (Net Debt 7.00b / FCF TTM 1.68b)
Total Stockholder Equity = 10.5b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.12% (Net Income 1.54b / Total Assets 25.1b)
RoE = 14.67% (Net Income TTM 1.54b / Total Stockholder Equity 10.5b)
RoCE = 16.83% (EBIT 2.96b / Capital Employed (Equity 10.5b + L.T.Debt 7.07b))
RoIC = 11.99% (NOPAT 2.26b / Invested Capital 18.8b)
WACC = 7.59% (E(28.6b)/V(37.6b) * Re(9.06%) + D(9.00b)/V(37.6b) * Rd(3.83%) * (1-Tc(0.24)))
Discount Rate = 9.06% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -95.56 | Cagr: -2.93%
[DCF] Terminal Value 73.10% ; FCFF base≈1.94b ; Y1≈1.70b ; Y5≈1.38b
[DCF] Fair Price = 18.08 (EV 22.1b - Net Debt 7.00b = Equity 15.1b / Shares 835.4m; r=8.35% [WACC [floored]]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: -77.46 | EPS CAGR: -9.42% | SUE: 0.90 | # QB: 3
Revenue Correlation: -65.11 | Revenue CAGR: -1.32% | SUE: 0.67 | # QB: 0
EPS current Quarter (2026-06-30): EPS=0.54 | Chg30d=+0.20% | Revisions=+17% | Analysts=21
EPS next Quarter (2026-09-30): EPS=0.61 | Chg30d=+0.38% | Revisions=+57% | Analysts=21
EPS current Year (2026-12-31): EPS=2.37 | Chg30d=+0.22% | Revisions=+62% | GrowthEPS=-1.9% | GrowthRev=+0.1%
EPS next Year (2027-12-31): EPS=2.93 | Chg30d=+0.80% | Revisions=+67% | GrowthEPS=+23.3% | GrowthRev=+6.1%
[Analyst] Revisions Ratio: +76% (up=17, down=1)